Innovation

Assay to Detect Hepcidin

Children's Hospital Boston
posted on 08/31/2011

Hepcidin is the master regulatory signal for iron homeostasis. Hepcidin is a small peptide with several different forms, some active and others inactive precursors or breakdown products. Elevated hepcidin is associated with anemia resulting from many conditions; decreased hepcidin can lead to iron overload. Although measurement of hepcidin is not yet a standard parameter in clinical diagnostics, many think it will become a valuable measure of iron status in a wide number of iron-related diseases. || Mass spectrometry is ideal for measurement of hepcidin (able to detect small peptides, reliable quantification, and excellent ability to distinguish different forms). Children's investigators have developed a method for MALDI-TOF detection of hepcidin using a 384-spot MALDI target chip that has the ability to concentrate and enrich the hepcidin from blood, plasma, serum or urine samples. Hepcidin is detected in a single analytic step with minimal sample pre-processing, allowing rapid processing of samples in parallel for high throughput.


Innovation Details
 

File Number: CMCC 1535 

Other Information: *Investigator(s)*
Hanno Steen

*Contact*
Connie Caron, Connie.Caron@childrens.harvard.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact David Altman at Children's Hospital Boston for more information.

Request more info via email request more info
People

Case Manager:

David Altman David Altman

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...